Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
STAT+
The Readout

Money is flowing into biotech again & Trump may tap a Theranos booster

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan Nov. 21, 2016

Reprints
The READOUT
Alex Hogan/STAT

The Readout for November 21, 2016

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

With CRISPR cures on horizon, sickle cell patients ask…
With CRISPR cures on horizon, sickle cell patients ask hard questions about who can access them
New guidelines on severe brain injury complicate already difficult…
New guidelines on severe brain injury complicate already difficult decisions
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories